Extracts from Allium pseudojaponicum Makino Target STAT3 Signaling Pathway to Overcome Cisplatin Resistance in Lung Cancer
Marine Drugs · 2025
DOI: 10.3390/md23040167 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2025. Verfasst von Soo-Bin Nam und 9 weiteren Autor:innen. Beteiligte Einrichtung: Biopharmaceutical Research Center, Korea Basic Science Institute (KBSI), Cheongju 28119, Republic of Korea. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Cisplatin, Lung Neoplasms, Plant Extracts. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF), National Research Council of Science & Technology (NST), Korea Basic Science Institute.
Abstract (Originalsprache)
Lung cancer, particularly non-small-cell lung cancer (NSCLC), remains a leading cause of cancer-related mortality, with cisplatin-based chemotherapy being a standard treatment. However, the development of chemoresistance significantly limits its efficacy, necessitating alternative therapeutic approaches. Here, we demonstrate the anticancer effects of the extracts of Allium pseudojaponicum Makino (APE), a salt-tolerant plant, in cisplatin-resistant NSCLC. Metabolite profiling using UPLC-Q-TOF-MSE identified 13 major compounds, predominantly alkaloids (71.65%) and flavonoids (8.81%), with key bioactive constituents such as lycorine (29.81%), tazettine (17.22%), and tricetin (8.19%). APE significantly inhibited cell viability in A549 and H460 cells, reducing viability to 38.6% (A549-Ctr), 37.2% (A549-CR), 28.4% (H460-Ctr), and 30.4% (H460-CR) at 40 µg/mL after 48 h. APE also suppressed colony formation by over 90% in both 2D and soft agar assays, while showing no cytotoxicity in normal human keratinocytes up to 80 µg/mL. Flow cytometry analysis revealed APE-induced G1 phase arrest, with the G1 population increasing from 50.4% to 56.6% (A549-Ctr) and 47.5% to 58.4% (A549-CR), accompanied by reduced S phase populations. This effect was associated with the downregulation of G1/S transition regulators, including cyclin D1, CDK4, cyclin E, and CDK2. Furthermore, proteomic analysis identified STAT3 signaling as a major target of APE; APE decreased phosphorylated STAT3 and c-Myc expression, and STAT3 knockdown phenocopied the effects of APE. These findings highlight the potential of APE as a natural product-based therapeutic strategy for overcoming cisplatin resistance in NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biopharmaceutical Research Center, Korea Basic Science Institute (KBSI), Cheongju 28119, Republic of Korea.
- College of Pharmacy, The Catholic University of Korea, Bucheon 14662, Republic of Korea.
- Digital Omics Research Center, Korea Basic Science Institute (KBSI), Cheongju 28119, Republic of Korea.
- College of Pharmacy, Chungnam National University, Daejeon 34134, Republic of Korea.
- College of Korean Medicine, Dongshin University, Naju 58245, Republic of Korea.
- Department of Korean Medicine, College of Korean Medicine, Woosuk University, Jeonju 55338, Republic of Korea.
ORCID-Profile: Soo-Bin Nam, Jung Hoon Choi, Ga-Eun Lee, Mee-Hyun Lee, Yong-Yeon Cho, Hye Gwang Jeong, Geul Bang, Cheol-Jung Lee
Förderung
- National Research Foundation of Korea (NRF)
- National Research Council of Science & Technology (NST)
- Korea Basic Science Institute
- National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT)
- National Research Council of Science & Technology (NST) grant by the Korean government (MSIT)
Zitieren
APA
Nam, S. B., Choi, J. H., Lee, G. E., Kim, J. Y., Lee, M. H., Yang, G., Cho, Y. Y., Jeong, H. G., Bang, G., & Lee, C. J. (2025). Extracts from Allium pseudojaponicum Makino Target STAT3 Signaling Pathway to Overcome Cisplatin Resistance in Lung Cancer. Marine Drugs. https://doi.org/10.3390/md23040167
Vancouver
Nam SB, Choi JH, Lee GE, Kim JY, Lee MH, Yang G, et al. Extracts from Allium pseudojaponicum Makino Target STAT3 Signaling Pathway to Overcome Cisplatin Resistance in Lung Cancer. Marine Drugs. 2025. doi:10.3390/md23040167
BibTeX
@article{Nam2025,
author = {Nam, Soo-Bin and Choi, Jung Hoon and Lee, Ga-Eun and Kim, Jin Young and Lee, Mee-Hyun and Yang, Gabsik and Cho, Yong-Yeon and Jeong, Hye Gwang and Bang, Geul and Lee, Cheol-Jung},
title = {Extracts from Allium pseudojaponicum Makino Target STAT3 Signaling Pathway to Overcome Cisplatin Resistance in Lung Cancer},
journal = {Marine Drugs},
year = {2025},
doi = {10.3390/md23040167}
}
EUVIMED